DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,036 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,733,535 | +3.8% | 75,508 | +0.4% | 1.22% | +9.9% |
| Q2 2023 | $18,048,480 | -6.2% | 75,202 | -1.5% | 1.11% | -12.4% |
| Q1 2023 | $19,242,498 | -22.7% | 76,347 | -18.6% | 1.26% | -26.3% |
| Q4 2022 | $24,884,718 | +1.8% | 93,756 | -0.9% | 1.71% | -4.8% |
| Q3 2022 | $24,446,000 | +1.2% | 94,646 | -0.7% | 1.80% | +9.2% |
| Q2 2022 | $24,160,000 | -10.5% | 95,297 | -0.9% | 1.65% | +4.4% |
| Q1 2022 | $27,001,000 | -19.1% | 96,177 | -5.2% | 1.58% | -8.6% |
| Q4 2021 | $33,387,000 | +8.8% | 101,477 | +0.6% | 1.73% | -1.3% |
| Q3 2021 | $30,700,000 | +12.2% | 100,840 | -1.1% | 1.75% | +11.2% |
| Q2 2021 | $27,368,000 | -1.3% | 101,981 | -16.7% | 1.57% | -4.9% |
| Q1 2021 | $27,723,000 | -0.4% | 122,379 | -2.3% | 1.66% | -6.9% |
| Q4 2020 | $27,821,000 | -1.5% | 125,239 | -4.5% | 1.78% | -11.4% |
| Q3 2020 | $28,235,000 | +17.7% | 131,124 | -3.4% | 2.01% | +9.9% |
| Q2 2020 | $23,993,000 | +15.3% | 135,684 | -9.8% | 1.83% | -3.6% |
| Q1 2020 | $20,817,000 | -13.4% | 150,402 | -4.0% | 1.89% | +9.5% |
| Q4 2019 | $24,050,000 | +6.2% | 156,698 | -0.0% | 1.73% | -1.3% |
| Q3 2019 | $22,638,000 | +1.0% | 156,742 | -0.1% | 1.75% | +0.2% |
| Q2 2019 | $22,424,000 | +5.8% | 156,902 | -2.3% | 1.75% | -0.8% |
| Q1 2019 | $21,194,000 | +27.1% | 160,533 | -0.8% | 1.76% | +9.6% |
| Q4 2018 | $16,680,000 | -5.4% | 161,755 | -0.3% | 1.61% | +14.8% |
| Q3 2018 | $17,634,000 | +10.8% | 162,285 | +0.6% | 1.40% | +2.6% |
| Q2 2018 | $15,915,000 | +0.7% | 161,275 | -0.0% | 1.37% | -2.6% |
| Q1 2018 | $15,797,000 | +5.4% | 161,343 | -0.1% | 1.40% | +10.6% |
| Q4 2017 | $14,986,000 | +8.6% | 161,450 | +0.3% | 1.27% | +6.4% |
| Q3 2017 | $13,805,000 | +2.1% | 160,931 | +0.4% | 1.19% | -2.3% |
| Q2 2017 | $13,521,000 | -0.5% | 160,222 | +0.9% | 1.22% | -4.5% |
| Q1 2017 | $13,584,000 | +10.4% | 158,827 | +0.5% | 1.28% | +5.1% |
| Q4 2016 | $12,307,000 | -0.4% | 158,107 | +0.3% | 1.22% | -2.2% |
| Q3 2016 | $12,355,000 | -0.7% | 157,615 | +27.9% | 1.24% | -2.4% |
| Q2 2016 | $12,447,000 | +28.1% | 123,240 | +20.4% | 1.28% | +24.6% |
| Q1 2016 | $9,714,000 | +4.0% | 102,400 | +1.9% | 1.02% | +4.4% |
| Q4 2015 | $9,336,000 | -1.4% | 100,520 | -9.6% | 0.98% | -5.1% |
| Q3 2015 | $9,471,000 | +181.5% | 111,145 | +182.7% | 1.03% | +201.5% |
| Q2 2015 | $3,365,000 | -2.3% | 39,320 | -3.0% | 0.34% | -2.8% |
| Q1 2015 | $3,443,000 | -2.2% | 40,550 | -1.3% | 0.35% | -0.8% |
| Q4 2014 | $3,520,000 | +13.6% | 41,070 | +0.7% | 0.36% | +9.9% |
| Q3 2014 | $3,098,000 | -8.9% | 40,770 | -5.7% | 0.32% | -8.0% |
| Q2 2014 | $3,402,000 | +7.1% | 43,215 | +2.1% | 0.35% | +3.5% |
| Q1 2014 | $3,175,000 | -2.3% | 42,335 | +0.5% | 0.34% | +4.9% |
| Q4 2013 | $3,251,000 | +9.5% | 42,115 | -1.7% | 0.32% | 0.0% |
| Q3 2013 | $2,970,000 | +9.2% | 42,840 | -0.3% | 0.32% | +2.9% |
| Q2 2013 | $2,721,000 | – | 42,980 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |